Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

By F. Ovalle. 2009

786 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/f9eae61e3d971c1f19da38d1e369e775682b404e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Genetics

In Surgery

Citations in the corpus

The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring (2016, background): “There is not yet conclusive evidence that RT-CGM reduces the number of hypoglycemic events, including severe episodes, but data support the role of RT-CGM in reducing moderate hypoglycemia as well as the time spent in hypoglycemic range.(34,35) Although clinical trials of RT-CGM have largely failed ”
Glucose Biosensors: An Overview of Use in Clinical Practice (2010, background): “Although CGM can be associated with improved glycemic control in adults and children with type 1 diabetes [84-86], the clinical usefulness of CGMS has not yet been established [87].”
Chapter 1: Epidemiology of Type 1 Diabetes (2010, neutral): “(R25 years) but not in participants aged 5 to 14 years or 15 to 24 years when subjects assigned to CGM use were compared with the controls.(94) However, when further stratified by CGM use, reductions in A1c were observed among children and young adults who wore the CGM for at least 6 days a week dur”
Analysis (2015, background): “Theoretically, improving these barriers will enhance adherence to RT-CGM, which might result in better glycemic outcomes and quality of life.(5) Therefore, improving the technical capabilities of RT-CGM systems remains essential.”
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, neutral): “1% (approximately 60 to 54 mmol/mol), compared with the usual intensive insulin therapy with SMBG (150).”
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, neutral): “Measurement in the last setting, self-monitoring of blood glucose (SMBG), was performed at least once per day by 40% and 26% of individuals with type 1 and type 2 diabetes, respectively, in the US in 1993 (90 ).”